We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
37 hedge funds and large institutions have $18.9M invested in Corvus Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
900% more call options, than puts
Call options by funds: $10K | Put options by funds: $1K
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
4% more capital invested
Capital invested by funds: $18.1M → $18.9M (+$775K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.25% less ownership
Funds ownership: 45.9% → 44.65% (-1.3%)
12% less funds holding
Funds holding: 42 → 37 (-5)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
37
Holders Change
-5
Holders Change %
-11.9%
% of All Funds
0.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
7
Reduced
5
Closed
6
Calls
$10K
Puts
$1K
Net Calls
+$9K
Net Calls Change
+$17K
Top Buyers
| 1 |
Millennium Management
New York
|
+$101K |
| 2 |
Morgan Stanley
New York
|
+$21.5K |
| 3 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$19.4K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.15K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.93K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$111K |
| 2 |
Two Sigma Investments
New York
|
-$60.2K |
| 3 |
Two Sigma Advisers
New York
|
-$57K |
| 4 |
CA
CHI Advisors
New York
|
-$35.1K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$16.7K |
